An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

Authors:

Abstract
A hydrogel binds to inflamed tissues, delivering therapeutics locally and reducing systemic drug exposure in mouse models of inflammatory bowel disease.
Funding Information
  • NIH (CA112663, T32DK7191-38-S1, DE013023, EB000244, DE023432, AR063866)
  • Alexander von Humboldt Foundation
  • Harvard Institute of Translational Immunology/Helmsley Trust Pilot

This publication has 40 references indexed in Scilit: